Aesthetics Journal

Latest features

Key considerations for practitioners interested in adding absorbable threads to their treatment portfolio

Aesthetics investigates the updated MHRA guidelines for patient safety and what this means for dermal filler classification

Dr Arti Singh debates the pros and cons of marking up injection points before injectable treatment

Special Feature: Introducing Thread Lifting

Key considerations for practitioners interested in adding absorbable threads to their treatment portfolio
News Special: Controlling Dermal Filler Regulation

By Ellie Holden

Aesthetics investigates the updated MHRA guidelines for patient safety and what this means for dermal filler classification

Almirall to refinance US medical dermatology acquisition

In September, Spanish pharmaceutical company Almirall acquired Allergan’s US medical dermatology unit portfolio by using a €400 million bridge loan. It acquired brands Aczone (dapsone), Tazorac (tazarotene), Azelex (azelaic acid) and Cordran Tape (fludroxycortide).
Almirall acquires Allergan’s US dermatology portfolio

Spanish pharmaceutical company Almirall has entered into an agreement to acquire Allergan’s US medical dermatology unit portfolio, consisting of five brands for acne and dermatoses treatment.